Font Size: a A A
Keyword [No-reflow]
Result: 21 - 40 | Page: 2 of 10
21. The Effects Of Ligustrazine On Myocardium Perfusion In Patients With Acute ST Segment Elevation Myocardial Infarction After Emergency Percutaneous Coronary Intervention
22. The Effect Of Ligustrazin On The No-reflow Phenomenon After Restoration Of Coronary Blood Flow In Rabbits With Experimental Acute Myocardial Infarction
23. Predictive Foctors For Development Of The No-reflow Phenomeon In Patients With Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention And Assessment The Long Term Prognostic
24. Analysis On The Risk Factors Of Coronary Artery Restenosis In CAD Patients After PTCA
25. Development Of Myocardial Perfusion And The Clinical Meaning In Patients With Acute Myocardial Infarction After The Emergency Percutaneous Coronary Intervention
26. Relative Factors For Angiographic No Reflow Phenomenon After Primary Percutaneous Coronary Intervention With Acute Myocardial Infarction
27. Analysis Of Influencing Factors Of Coronary Flow And Myocardial Perfusion After Direct PCI In Patients With Acute Myocardial Infarction And Effect On Short-term Prognosis
28. Correlation Between No-reflow And Thrombomodulin In Reperfused Pateints With Acute Myocardial Infarction
29. The Effect Of Dexamethasone On The No-reflow Phenomenon After Restoration Of Coronary Blood Flow In Rabbits With Experimental Acute Myocardial Infarction
30. Analysis On The Risk Factors And Relatetive Evaluation Related To The "No-Reflow" Phenomenon After Reperfusion Therapy Of Emergent Percutaneous Coronary Intervention
31. Effect Of Intracoronary Administration Of Anisodamine On No-reflow Phenomenon Following Primary PCI In Patients With AMI
32. Clinical Analysis Of No-reflow Phenomenon After Emergency PCI In AMI Patients
33. Effects And Mechanisms Of Tirofiban On Anatomic No Reflow And Ventricular Remodeling After Myocardial Ischemia/reperfusion In Rats
34. Effect Of Intracoronary Administration Of Anisodamine On No-reflow Phenomenon In York Pig
35. Clinical Research For No Reflow Phenomenon After Direct PCI With AMI
36. Effect And Potential Mechanisms Of Short-term Use Of Simvastatin On Myocardial No-reflow After Ischemia-reperfusion In Rats
37. Relative Factors For Angiographic No Reflow Phenomenon After Primary Percutaneous Coronary Intervention In Patients With Acute Myocardial Infarction
38. The Effect Of Rosiglitazone On The No-reflow Phenomenon After Restoration Of Coronary Blood Flow In Rats With Experimental Acute Myocardial Infarction
39. The Use Of Plasma B-type Natriuretic Peptide Levels In Evaluation Of Prognosis And Risk Stratification Of Different Therapy In Patients With Acute Coronary Syndrome
40. The Discussion Of Relevant Factors Led To The Occurrence Of No-reflow Phenomenon In Emergency PCI Of Acute Myocardial Infarction
  <<First  <Prev  Next>  Last>>  Jump to